• 1
    Guyer B, MacDorman MF, Martin JA, Peters KD, Strobino DM. Annual summary of vital statistics – 1997. Pediatrics 1998; 102:13331349.
  • 2
    Kramer MS. Intrauterine growth and gestational duration determinants. Pediatrics 1987; 80:502511.
  • 3
    Dyson DC, Danbe KH, Bamber JA, Crites YM, Field DR, Maier JA, et al. Monitoring women at risk for preterm labor [see comments]. New England Journal of Medicine 1998; 338:1519.
  • 4
    Goldenberg RL & Rouse DJ. Prevention of premature birth [see comments]. New England Journal of Medicine 1998; 339:313320.
  • 5
    Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad AH, Copper RL, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network [see comments]. American Journal of Public Health 1998; 88:233238.
  • 6
    Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. New England Journal of Medicine 2000; 342:534540.
  • 7
    Collaborative Group on Preterm Birth Prevention. Multicenter randomized controlled trial of a preterm birth prevention program. [see comments]. American Journal of Obstetrics and Gynecology. 1993; 169(2 Part 1):352366.
  • 8
    Johnstone F & Inglis L. Familial trends in low birth weight. British Medical Journal 1974; 3:659661.
  • 9
    Magnus P, Bakketeig LS, Skjaerven R. Correlations of birth weight and gestational age across generations. Annals of Human Biology 1993; 20:231238.
  • 10
    Porter TF, Fraser AM, Hunter CY, Ward RH, Varner MW. The risk of preterm birth across generations. Obstetrics and Gynecology 1997; 90:6367.
  • 11
    Hackman E, Emanuel I, Van Belle G, Daling J. Maternal birth weight and subsequent pregnancy outcome. JAMA 1983; 250:20162019.
  • 12
    Klebanoff MA, Graubard BI, Kessel SS, Berendes HW. Low birth weight across generations. JAMA 1984; 252:24232427.
  • 13
    Klebanoff MA & Yip R. Influence of maternal birth weight on rate of fetal growth and duration of gestation. Journal of Pediatrics 1987; 111:287292.
  • 14
    Carr-Hill RA & Hall MH. The repetition of spontaneous preterm labour. British Journal of Obstetrics and Gynaecology 1985; 92:921928.
  • 15
    Bakketeig LS, Hoffman HJ, Harley EE. The tendency to repeat gestational age and birth weight in successive births. American Journal of Obstetrics and Gynecology 1979; 135:10861103.
  • 16
    Wang X, Zuckerman B, Coffman GA, Corwin MJ. Familial aggregation of low birth weight among whites and blacks in the United States [see comments]. New England Journal of Medicine 1995; 333:17441749.
  • 17
    Adams MM, Elam-Evans LD, Wilson HG, Gilbertz DA. Rates of and factors associated with recurrence of preterm delivery. JAMA 2000; 283:15911596.
  • 18
    Savitz DA, Blackmore CA, Thorp JM. Epidemiologic characteristics of preterm delivery: etiologic heterogeneity. American Journal of Obstetrics and Gynecology 1991; 164:467471.
  • 19
    Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. American Journal of Obstetrics and Gynecology 1992; 166:15151528.
  • 20
    Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, et al. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network [see comments]. American Journal of Obstetrics and Gynecology 1995; 173:12311235.
  • 21
    Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group [see comments]. New England Journal of Medicine 1995; 333:17371742.
  • 22
    Sobel JD. Vaginitis [see comments]. New England Journal of Medicine 1997; 337:18961903.
  • 23
    Eschenbach DA, Nugent RP, Rao AV, Cotch MF, Gibbs RS, Lipscomb KA, et al. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group [see comments]. American Journal of Obstetrics and Gynecology 1991; 164:734742.
  • 24
    Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis [see comments]. New England Journal of Medicine 1995; 333:17321736.
  • 25
    Brocklehurst P. Infection and preterm delivery [editorial]. British Medical Journal 1999; 318:548549.
  • 26
    Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units [see comments]. New England Journal of Medicine 2000; 342:534540.
  • 27
    Graham JM, Oshiro BT, Blanco JD, Magee KP. Uterine contractions after antibiotic therapy for pyelonephritis in pregnancy. American Journal of Obstetrics and Gynecology 1993; 168:577580.
  • 28
    Madinger NE, Greenspoon JS, Ellrodt AG. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? American Journal of Obstetrics and Gynecology 1989; 161:657662.
  • 29
    Mazze RI & Kallen B. Appendectomy during pregnancy: a Swedish registry study of 778 cases. Obstetrics and Gynecology 1991; 77:835840.
  • 30
    Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. Journal of Periodontology 1996; 67(10 Suppl.):11031113.
  • 31
    Laham N, Rice GE, Bishop GJ, Hansen MB, Bendtzen K, Brennecke SP. Elevated plasma interleukin 6: a biochemical marker of human preterm labour. Gynecologic and Obstetric Investigation 1993; 36:145147.
  • 32
    Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993; 5:8188.
  • 33
    Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstetrics and Gynecology 1993; 81:941948.
  • 34
    Foulon W, Van Liedekerke D, Demanet C, Decatte L, Dewaele M, Naessens A. Markers of infection and their relationship to preterm delivery. American Journal of Perinatology 1995; 12:208211.
  • 35
    Ohno Y, Kasugai M, Kurauchi O, Mizutani S, Tomoda Y. Effect of interleukin 2 on the production of progesterone and prostaglandin E2 in human fetal membranes and its consequences for preterm uterine contractions. European Journal of Endocrinology 1994; 130:478484.
  • 36
    Romero R, Kadar N, Hobbins JC, Duff GW. Infection and labor: the detection of endotoxin in amniotic fluid. American Journal of Obstetrics and Gynecology 1987; 157(4 Part 1):815819.
  • 37
    Romero R, Durum S, Dinarello CA, Oyarzun E, Hobbins JC, Mitchell MD. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989; 37:1322.
  • 38
    Romero R, Brody DT, Oyarzun E, Mazor M, Wu YK, Hobbins JC, et al. Infection and labor. III. Interleukin-1: a signal for the onset of parturition. American Journal of Obstetrics and Gynecology 1989; 160(5 Part 1):11171123.
  • 39
    Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB, et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. American Journal of Reproductive Immunology 1992; 27:117123.
  • 40
    Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. American Journal of Obstetrics and Gynecology 1992; 166:15761587.
  • 41
    Potter N, Kosuda L, Bigazzi P. Relationships among cytokines (IL-1, TNF, and IL-8) and histologic markers of acute ascending intrauterine infection. Journal of Maternal-Fetal Medicine 1992; 1:142147.
  • 42
    Lundin-Schiller S, Mitchell MD. Prostaglandin production by human chorion laeve cells in response to inflammatory mediators. Placenta 1991; 12:353363.
  • 43
    Casey ML, Cox SM, Beutler B, Milewich L, MacDonald PC. Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor. Journal of Clinical Investigation 1989; 83:430436.
  • 44
    Norwitz ER, Lopez Bernal A, Starkey PM. Tumor necrosis factor-alpha selectively stimulates prostaglandin F2 alpha production by macrophages in human term decidua. American Journal of Obstetrics and Gynecology 1992; 167:815820.
  • 45
    Mitchell MD, Lundin-Schiller S, Edwin SS. Endothelin production by amnion and its regulation by cytokines. American Journal of Obstetrics and Gynecology 1991; 165:120124.
  • 46
    Romero R, Wu YK, Mazor M, Hobbins JC, Mitchell MD. Amniotic fluid prostaglandin E2 in preterm labor. Prostaglandins Leukotrienes and Essential Fatty Acids 1988; 34:141145.
  • 47
    Romero R, Munoz H, Gomez R, Parra M, Polanco M, Valverde V, et al. Increase in prostaglandin bioavailability precedes the onset of human parturition[published erratum appears in Prostaglandins Leukotrienes and Essential Fatty Acids, 1996; 55: 458]Prostaglandins Leukotrienes and Essential Fatty Acids 1996; 54:187191.
  • 48
    Dudley DJ, Trautman MS, Araneo BA, Edwin SS, Mitchell MD. Decidual cell biosynthesis of interleukin-6: regulation by inflammatory cytokines. Journal of Clinical Endocrinology and Metabolism 1992; 74:884889.
  • 49
    Dudley DJ, Trautman MS, Edwin SS, Lundin-Schiller S, Mitchell MD. Biosynthesis of interleukin-6 by cultured human chorion laeve cells: regulation by cytokines. Journal of Clinical Endocrinology and Metabolism 1992; 75:10811086.
  • 50
    Katsura M, Ito A, Hirakawa S, Mori Y. Human recombinant interleukin-1 alpha increases biosynthesis of collagenase and hyaluronic acid in cultured human chorionic cells. FEBS Letters 1989; 244:315318.
  • 51
    Ito A, Sato T, Ojima Y, Chen LC, Nagase H, Mori Y. Calmodulin differentially modulates the interleukin 1-induced biosynthesis of tissue inhibitor of metalloproteinases and matrix metalloproteinases in human uterine cervical fibroblasts. Journal of Biological Chemistry 1991; 266:1359813601.
  • 52
    Schatz F, Papp C, Aigner S, Krikun G, Hausknecht V, Lockwood CJ. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression. Journal of Clinical Endocrinology and Metabolism 1997; 82:188193.
  • 53
    Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. New England Journal of Medicine 2000; 342:15001507.
  • 54
    Berkowitz GS & Kasl SV. The role of psychosocial factors in spontaneous preterm delivery. Journal of Psychosomatic Research 1983; 27:283290.
  • 55
    Berkowitz GS & Papiernik E. Epidemiology of preterm birth. Epidemiologic Reviews 1993; 15:414443.
  • 56
    Berkowitz GS. An epidemiologic study of preterm delivery. American Journal of Epidemiology 1981; 113:8192.
  • 57
    Kleinman JC & Kessel SS. Racial differences in low birth weight. Trends and risk factors. New England Journal of Medicine 1987; 317:749753.
  • 58
    Behrman RE. Premature births among black women [editorial]. New England Journal of Medicine 1987; 317:763765.
  • 59
    Newton RW, Webster PA, Binu PS, Maskrey N, Phillips AB. Psychosocial stress in pregnancy and its relation to the onset of premature labour. British Medical Journal 1979; 2:411413.
  • 60
    Omer H, Elizur Y, Barnea T, Friedlander D, Palti Z. Psychological variables and premature labour: a possible solution for some methodological problems. Journal of Psychosomatic Research 1986; 30:559565.
  • 61
    Lobel M, Dunkel-Schetter C, Scrimshaw SC. Prenatal maternal stress and prematurity: a prospective study of socioeconomically disadvantaged women. Health Psychology 1992; 11:3240.
  • 62
    Dijkstra K, Janssen HC, Kuczynski E, Lockwood CJ. Cervical length in uncomplicated pregnancy: a study of sociodemographic predictors of cervical changes across gestation. American Journal of Obstetrics and Gynecology 1999; 180(3 Part 1):639644.
  • 63
    Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. American Journal of Obstetrics and Gynecology 1993; 168:585591.
  • 64
    Salafia CM. Placental pathology of fetal growth restriction. Clinical Obstetrics and Gynecology 1997; 40:740749.
  • 65
    Makrigiannakis A, Zoumakis E, Margioris AN, Stournaras C, Chrousos GP, Gravanis A. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology 1996; 64:8592.
  • 66
    Petraglia F, Sawchenko PE, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987; 328:717719.
  • 67
    Saijonmaa O, Laatikainen T, Wahlstrom T. Corticotrophin-releasing factor in human placenta: localization, concentration and release in vitro. Placenta 1988; 9:373385.
  • 68
    Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. Journal of Clinical Endocrinology and Metabolism 1989; 68:825830.
  • 69
    Jones CT. Endocrine function of the placenta. Baillieres Clinical Endocrinology and Metabolism 1989; 3:755780.
  • 70
    Jones SA & Challis JR. Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta. Biochemical and Biophysical Research Communications 1989; 159:192199.
  • 71
    Jones CT, Gu W, Parer JT. Production of corticotrophin releasing hormone by the sheep placenta in vivo. Journal of Developmental Physiology 1989; 11:97101.
  • 72
    Lockwood CJ, Radunovic N, Nastic D, Petkovic S, Aigner S, Berkowitz GS. Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. Journal of Perinatal Medicine 1996; 24:243251.
  • 73
    McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy [see comments]. Nature Medicine 1995; 1:460463.
  • 74
    Sasaki A, Shinkawa O, Margioris AN, Liotta AS, Sato S, Murakami O, et al. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. Journal of Clinical Endocrinology and Metabolism 1987; 64:224229.
  • 75
    Campbell EA, Linton EA, Wolfe CD, Scraggs PR, Jones MT, Lowry PJ. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. Journal of Clinical Endocrinology and Metabolism 1987; 64:10541059.
  • 76
    Karalis K, Goodwin G, Majzoub JA. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nature Medicine 1996; 2:556560.
  • 77
    Tropper PJ, Warren WB, Jozak SM, Conwell IM, Stark RI, Goland RS. Corticotropin releasing hormone concentrations in umbilical cord blood of preterm fetuses. Journal of Developmental Physiology 1992; 18:8185.
  • 78
    Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213:13941397.
  • 79
    Wadhwa PD, Dunkel-Schetter C, Chicz-DeMet A, Porto M, Sandman CA. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosomatic Medicine 1996; 58:432446.
  • 80
    Economides DL, Nicolaides KH, Linton EA, Perry LA, Chard T. Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Therapy 1988; 3:158164.
  • 81
    Petraglia F, Coukos G, Volpe A, Genazzani AR, Vale W. Involvement of placental neurohormones in human parturition. Annals of the New York Academy of Sciences 1991; 622:331340.
  • 82
    Jones SA & Challis JR. Steroid, corticotrophin-releasing hormone, ACTH and prostaglandin interactions in the amnion and placenta of early pregnancy in man. Journal of Endocrinology 1990; 125:153159.
  • 83
    Neulen J & Breckwoldt M. Placental progesterone, prostaglandins and mechanisms leading to initiation of parturition in the human. Experimental and Clinical Endocrinology 1994; 102:195202.
  • 84
    Grazul-Bilska AT, Redmer DA, Johnson ML, Jablonka-Shariff A, Bilski JJ, Reynolds LP. Gap junctional protein connexin 43 in bovine corpora lutea throughout the estrous cycle[published erratum appears in Biology of Reproduction 1996; 55: 1185]Biology of Reproduction 1996; 54:12791287.
  • 85
    Rath W, Osmers R, Adelmann-Grill BC, Stuhlsatz HW, Szevereny M, Kuhn W. Biochemical changes in human cervical connective tissue after intracervical application of prostaglandin E2. Prostaglandins 1993; 45:375384.
  • 86
    Siiteri PK & MacDonald PC. Placental estrogen biosynthesis during human pregnancy. Journal of Clinical Endocrinology and Metabolism 1966; 26:751761.
  • 87
    Lye SJ, Nicholson BJ, Mascarenhas M, MacKenzie L, Petrocelli T. Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen: progesterone ratio. Endocrinology 1993; 132:23802386.
  • 88
    Bale TL & Dorsa DM. Cloning, novel promoter sequence, and estrogen regulation of a rat oxytocin receptor gene. Endocrinology 1997; 138:11511158.
  • 89
    Windmoller R, Lye SJ, Challis JR. Estradiol modulation of ovine uterine activity. Canadian Journal of Physiology and Pharmacology 1983; 61:722728.
  • 90
    Matsui K, Higashi K, Fukunaga K, Miyazaki K, Maeyama M, Miyamoto E. Hormone treatments and pregnancy alter myosin light chain kinase and calmodulin levels in rabbit myometrium. Journal of Endocrinology 1983; 97:1119.
  • 91
    Klebanoff M. Conceptualizing categories of preterm birth. Prenatal and Neonatal Medicine 1998; 3:1315.
  • 92
    Williams MA, Mittendorf R, Lieberman E, Monson RR. Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstetrics and Gynecology 1991; 78:1418.
  • 93
    Harger JH, Hsing AW, Tuomala RE, Gibbs RS, Mead PB, Eschenbach DA, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. American Journal of Obstetrics and Gynecology 1990; 163(1 Part 1):130137.
  • 94
    Ekwo EE, Gosselink CA, Moawad A. Unfavorable outcome in penultimate pregnancy and premature rupture of membranes in successive pregnancy. Obstetrics and Gynecology 1992; 80:166172.
  • 95
    Ball RH, Ade CM, Schoenborn JA, Crane JP. The clinical significance of ultransonographically detected subchorionic hemorrhages. American Journal of Obstetrics and Gynecology 1996; 174:9961002.
  • 96
    Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium [see comments]. New England Journal of Medicine 2000; 342:374380.
  • 97
    Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. Journal of Medical Genetics 1997; 34:525526.
  • 98
    Motulsky AG. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid [editorial; comment][see comments][published erratum appears in American Journal of Human Genetics 1996; 58: 648]American Journal of Human Genetics 1996; 58:1720.
  • 99
    Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [letter]. Nature Genetics 1995; 10:111113.
  • 100
    Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations [see comments]. Circulation 1996; 93:79.
  • 101
    Van Der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? American Journal of Human Genetics 1998; 62:10441051.
  • 102
    Den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW, et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? [see comments]. Lancet 1995; 345:882885.
  • 103
    Den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [see comments]. New England Journal of Medicine 1996; 334:759762.
  • 104
    Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268:877881.
  • 105
    Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes [see comments]. JAMA 1995; 274:10491057.
  • 106
    Brattstrom L, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B, et al. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. European Journal of Clinical Investigation 1992; 22:214221.
  • 107
    Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease [see comments]. New England Journal of Medicine 1991; 324:11491155.
  • 108
    Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects [see comments]. Lancet 1995; 345:149151.
  • 109
    Rajkovic A, Catalano PM, Malinow MR. Elevated homocysteine levels with preeclampsia. Obstetrics and Gynecology 1997; 90:168171.
  • 110
    Dekker GA, De Vries JI, Doelitzsch PM, Huijgens PC, Von Blomberg BM, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. American Journal of Obstetrics and Gynecology 1995; 173:10421048.
  • 111
    Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, et al. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thrombosis and Haemostasis 1997; 77:10521054.
  • 112
    Burke G, Robinson K, Refsum H, Stuart B, Drumm J, Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels [letter]. New England Journal of Medicine 1992; 326:6970.
  • 113
    Steegers-Theunissen RP, Boers GH, Blom HJ, Trijbels FJ, Eskes TK. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae [letter]. Lancet 1992; 339:11221123.
  • 114
    Goddijn-Wessel TA, Wouters MG, Van De Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, et al. Hyperhomocysteinemia: a risk factor for placental abruption or infarction. European Journal of Obstetrics and Gynecology and Reproductive Biology 1996; 66:2329.
  • 115
    Selhub J & Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethio- nine of the remethylation and transsulfuration of homocysteine. American Journal of Clinical Nutrition 1992; 55:131138.
  • 116
    Kline J, Stein ZA, Susser M, Warburton D. Smoking: a risk factor for spontaneous abortion. New England Journal of Medicine 1977; 297:793796.
  • 117
    Windham GC, Swan SH, Fenster L. Parental cigarette smoking and the risk of spontaneous abortion. American Journal of Epidemiology 1992; 135:13941403.
  • 118
    Dlugosz L, Belanger K, Hellenbrand K, Holford TR, Leaderer B, Bracken MB. Maternal caffeine consumption and spontaneous abortion: a prospective cohort study. Epidemiology 1996; 7:250255.
  • 119
    Nurminen T. Maternal pesticide exposure and pregnancy outcome. Journal of Occupational and Environmental Medicine 1995; 37:935940.
  • 120
    Schwartz DA, Newsum LA, Heifetz RM. Parental occupation and birth outcome in an agricultural community. Scandinavian Journal of Work, Environment, and Health 1986; 12:5154.
  • 121
    Savitz DA, Whelan EA, Kleckner RC. Effect of parents’ occupational exposures on risk of stillbirth, preterm delivery, and small-for-gestational-age infants. American Journal of Epidemiology 1989; 129:12011218.
  • 122
    Brown-Woodman PD, Webster WS, Picker K, Huq F. In vitro assessment of individual and interactive effects of aromatic hydrocarbons on embryonic development of the rat. Reproductive Toxicology 1994; 8:121135.
  • 123
    Hersh JH, Podruch PE, Rogers G, Weisskopf B. Toluene embryopathy. Journal of Pediatrics 1985; 106:922927.
  • 124
    Lindbohm ML. Effects of parental exposure to solvents on pregnancy outcome. Journal of Occupational and Environmental Medicine 1995; 37:908914.
  • 125
    Ng TP, Foo SC, Yoong T. Menstrual function in workers exposed to toluene. British Journal of Industrial Medicine 1992; 49:799803.
  • 126
    Sallmen M, Lindbohm ML, Kyyronen P, Nykyri E, Anttila A, Taskinen H, et al. Reduced fertility among women exposed to organic solvents. American Journal of Industrial Medicine 1995; 27:699713.
  • 127
    Hirvonen A. Genetic factors in individual responses to environmental exposures. Journal of Occupational and Environmental Medicine 1995; 37:3743.
  • 128
    Timbrell J. Principles of Biochemical Toxicology. 2nd edn. Washington DC: Taylor & Francis, 1991.
  • 129
    Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Letters 1990; 263:131133.
  • 130
    Xu X, Kelsey KT, Wiencke JK, Wain JC, Christiani DC. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiology, Biomarkers and Prevention 1996; 5:687692.
  • 131
    Xu X, Wiencke JK, Niu T, Wang M, Watanabe H, Kelsey KT, et al. Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. American Journal of Industrial Medicine 1998; 33:157163.DOI: 10.1002/(sici)1097-0274(199802)33:2<157::aid-ajim7>;2-v
  • 132
    Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and mu-class glutathione S-transferase genes. Japanese Journal of Cancer Research 1992; 83:866870.
  • 133
    Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research 1991; 51:51775180.
  • 134
    Van Den Velden PA & Reitsma PH. Amino acid dimorphism in IL1A is detectable by PCR amplification. Human Molecular Genetics 1993; 2:1753.
  • 135
    Di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Human Molecular Genetics 1992; 1:450.
  • 136
    Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation 1998; 102:13691376.
  • 137
    Skoog T, Van'T Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C[RIGHTWARDS ARROW]A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Human Molecular Genetics 1999; 8:14431449.
  • 138
    Baerwald CG, Panayi GS, Lanchbury JS. A new XmnI polymorphism in the regulatory region of the corticotropin releasing hormone gene. Human Genetics 1996; 97:697698.
  • 139
    Arranz MJ, Dawson E, Shaikh S, Sham P, Sharma T, Aitchison K, et al. Cytochrome P4502D6 genotype does not determine response to clozapine. British Journal of Clinical Pharmacology 1995; 39:417420.
  • 140
    Farker K, Lehmann MH, Kastner R, Weber J, Janitzky V, Schubert J, et al. Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population. International Journal of Clinical Pharmacology and Therapeutics 2000; 38:3034.
  • 141
    Harada S & Zhang S. New strategy for detection of ALDH2 mutant. Alcohol and Alcoholism Supplement 1993 1A:1113.
  • 142
    Ozawa S, Schoket B, McDaniel LP, Tang YM, Ambrosone CB, Kostic S, et al. Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases. Carcinogenesis 1999; 20:991995.DOI: 10.1093/carcin/20.6.991
  • 143
    Wiencke JK, Pemble S, Ketterer B, Kelsey KT. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiology, Biomarkers and Prevention 1995; 4:253259.
  • 144
    Lee EJ, Zhao B, Moochhala SM, Ngoi SS. Frequency of mutant CYPIA1, NAT2 and GSTM1 alleles in a normal Chinese population. Pharmacogenetics 1994; 4:355358.
  • 145
    Smith CA, Wadelius M, Gough AC, Harrison DJ, Wolf CR, Rane A. A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. Journal of Medical Genetics 1997; 34:758760.
  • 146
    Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants[published erratum appears in Human Molecular Genetics 1994; 3: 1214]Human Molecular Genetics 1994; 3:421428.
  • 147
    Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics 1993; 52:506516.
  • 148
    Risch N & Merikangas K. The future of genetic studies of complex human diseases [see comments]. Science 1996; 273:15161517.
  • 149
    Allison DB. Transmission-disequilibrium tests for quantitative traits[published erratum appears in American Journal of Human Genetics 1997; 60: 1571]American Journal of Human Genetics 1997; 60:676690.
  • 150
    Morton NE & Collins A. Tests and estimates of allelic association in complex inheritance. Proceedings of the National Academy of Sciences of the USA 1998; 95:1138911393.
  • 151
    Collins A & Morton NE. Mapping a disease locus by allelic association. Proceedings of the National Academy of Sciences of the USA 1998; 95:17411745.
  • 152
    Rothman K & Greenland S. Modern Epidemiology. 2nd edn. Philadelphia, PA: Lippincott–Raven, 1998.
  • 153
    Aragaki C, Quiaoit F, Hsu L, Zhao LP. Mapping alcoholism genes using linkage/linkage disequilibrium analysis. Genetic Epidemiology 1999; 17(Suppl. 1):S43S48.
  • 154
    Savitz DA & Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic data [see comments]. American Journal of Epidemiology 1995; 142:904908.
  • 155
    Aragaki CC, Greenland S, Probst-Hensch N, Haile RW. Hierarchical modeling of gene – environment interactions: estimating NAT2 genotype-specific dietary effects on adenomatous polyps. Cancer Epidemiology, Biomarkers and Prevention 1997; 6:307314.
  • 156
    Wang X, Chen D, Nio T, Wang Z, Ryan L, Smith T, et al. Genetic susceptibility to benzene and shortened gestation: evidence of gene–environment interaction (see comments). American Journal of Epidemiology 2000; 152:693700.
  • 157
    Padungtod C, Niu T, Wang Z, Savitz DA, Christiani DC, Ryan LM, et al. Paraoxonase polymorphism and its effect on male reproductive outcomes among Chinese pesticide factory workers. American Journal of Industrial Medicine 1999; 36:379387.